The broad, long-term objectives of the Biostatistics Core (Core F) are to provide a full spectrum of statistical consulting services for HIV/AIDS-related research ofthe UNC CFAR.
The specific aims i nclude (1) providing a full spectrum of collaborative biostatistical services, (2) serving as a liaison between AIDS researchers and statistical scientists within the UNC CFAR research community and beyond, (3) providing scientific leadership, (4) providing biostatistical training and education to the UNC CFAR research community, and (5) engaging in evaluation and strategic planning to address the changing needs ofthe UNC CFAR. To achieve these aims, members of Core F proactively engage UNC CFAR investigators to identify and deliver services essential for highly productive design, management, analysis and publication ofAIDS research. Core F contributes to the framing of hypotheses, development of study designs, preparation of grant applications, selection of best statistical strategies, and delivery of statistical analyses required for publications. Investigators new to AIDS research receive highest priority. Core F also serves as a nexus between statistical and biomedical scientists in HIV research. Through the Core, clinicians are linked to statistical coinvestigators, while statisticians initiating AIDS-related methods research are connected with clinical coinvestigators. Organization as a formal Biostatistics Cpre greatly enhances the efficiency and ability of the Core to connect communities of scientists and to provide mentoring and training in statistics to AIDS researchers. Strong institutional support from the Department of Biostatistics allows Core F to take full advantage of existing infrastructure, resources and contacts with faculty renowned for their expertise in specialized fields of statistics. The Core proactively seeks Biostatistics faculty and students interested in participating as new members of Core F.
Consistent with the mission ofthe NIH CFAR Program, the Biostatistics Core delivers essential biostatistical support and expertise to HIV/AIDS investigators ofthe UNC CFAR. These collaborative contributions ensure investigators make measurements, inferences, and predictions that are accurate, precise, and relevant to their particular research goals.
|White, Becky L; Walsh, Joan; Rayasam, Swati et al. (2015) What Makes Me Screen for HIV? Perceived Barriers and Facilitators to Conducting Recommended Routine HIV Testing among Primary Care Physicians in the Southeastern United States. J Int Assoc Provid AIDS Care 14:127-35|
|Jennings, Larissa; Rompalo, Anne M; Wang, Jing et al. (2015) Prevalence and correlates of knowledge of male partner HIV testing and serostatus among African-American women living in high poverty, high HIV prevalence communities (HPTN 064). AIDS Behav 19:291-301|
|Rosen, David L; Golin, Carol E; Grodensky, Catherine A et al. (2015) Opt-out HIV testing in prison: informed and voluntary? AIDS Care 27:545-54|
|Evon, Donna M; Golin, Carol E; Bonner, Jason E et al. (2015) Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of patient-reported facilitators and barriers. J Clin Gastroenterol 49:e41-50|
|Joseph, Sarah B; Arrildt, Kathryn T; Sturdevant, Christa B et al. (2015) HIV-1 target cells in the CNS. J Neurovirol 21:276-89|
|Edwards, Jessie K; Cole, Stephen R; Adimora, Adaora et al. (2015) Illustration of a measure to combine viral suppression and viral rebound in studies of HIV therapy. J Acquir Immune Defic Syndr 68:241-4|
|Onsomu, Elijah O; Abuya, Benta A; Okech, Irene N et al. (2015) Association between domestic violence and HIV serostatus among married and formerly married women in Kenya. Health Care Women Int 36:205-28|
|O'Shea, Michele S; Rosenberg, Nora E; Hosseinipour, Mina C et al. (2015) Effect of HIV status on fertility desire and knowledge of long-acting reversible contraception of postpartum Malawian women. AIDS Care 27:489-98|
|Cole, Stephen R; Lau, Bryan; Eron, Joseph J et al. (2015) Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. Am J Epidemiol 181:238-45|
|Rahangdale, Lisa; De Paris, Kristina; Kashuba, Angela D M et al. (2015) Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women. J Acquir Immune Defic Syndr 68:420-4|
Showing the most recent 10 out of 624 publications